Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by W. Yasui
KIFC1 Inhibitor CW069 Induces Apoptosis and Reverses Resistance to Docetaxel in Prostate Cancer
European Urology, Supplements
Urology
Related publications
Manumycin Induces Apoptosis in Prostate Cancer Cells
OncoTargets and Therapy
Oncology
Pharmacology
Prostate Apoptosis Response-4 Is Involved in the Apoptosis Response to Docetaxel in McF-7 Breast Cancer Cells
International Journal of Oncology
Cancer Research
Oncology
PMA Induces Androgen Receptor Downregulation and Cellular Apoptosis in Prostate Cancer Cells
Journal of Molecular Endocrinology
Endocrinology
Molecular Biology
Gonadotropin-Releasing Hormone Induces Apoptosis of Prostate Cancer Cells
Cancer Research
Cancer Research
Oncology
Gossypol Induces Apoptosis by Activating P53 in Prostate Cancer Cells and Prostate Tumor-Initiating Cells
Molecular Cancer Therapeutics
Cancer Research
Oncology
Insulin-Like Growth Factor-I Induces Chemoresistence to Docetaxel by Inhibiting miR-143 in Human Prostate Cancer
Oncotarget
Oncology
DNA Mismatch Repair Gene MLH1 Induces Apoptosis in Prostate Cancer Cells
Oncotarget
Oncology
Bone Morphogenetic Protein-9 Induces Apoptosis in Prostate Cancer Cells, the Role of Prostate Apoptosis Response-4
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
Pantoprazole Affecting Docetaxel Resistance Pathways via Autophagy (PANDORA): Phase II Trial of High Dose Pantoprazole (Autophagy Inhibitor) With Docetaxel in Metastatic Castration‐Resistant Prostate Cancer (mCRPC)
Oncologist
Cancer Research
Medicine
Oncology